Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard

Marcio H Miname1, Marcio Sommer Bittencourt2, Sérgio R Moraes1

  • 1Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, Brazil.

Insights

Coronary artery calcium (CAC) scores effectively predict atherosclerotic cardiovascular disease (ASCVD) events in familial hypercholesterolemia (FH) patients on lipid-lowering therapy. Higher CAC scores indicate increased ASCVD risk, aiding in personalized treatment strategies.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Medical Imaging

Background:

  • Familial hypercholesterolemia (FH) significantly increases the risk of premature atherosclerotic cardiovascular disease (ASCVD).
  • The clinical presentation of ASCVD in FH patients is variable, necessitating refined risk stratification tools.
  • Coronary artery calcium (CAC) scoring is a valuable marker for subclinical atherosclerosis burden.

Purpose of the Study:

  • To assess the predictive value of coronary artery calcium (CAC) for atherosclerotic cardiovascular disease (ASCVD) events.
  • To evaluate CAC in asymptomatic primary prevention patients with molecularly proven heterozygous familial hypercholesterolemia (FH).
  • To determine the role of CAC in patients already receiving standard lipid-lowering therapy.

Main Methods:

  • Prospective follow-up of 206 FH subjects who underwent CAC measurement.
  • Multivariate analysis was employed to evaluate the association between CAC and ASCVD events.
  • Study included patients with a mean age of 45 years and high baseline LDL cholesterol levels.

Main Results:

  • Coronary artery calcium (CAC) was detected in 51% of the study participants.
  • A total of 15 ASCVD events (7.2%) occurred during a median follow-up of 3.7 years.
  • Log(CAC score + 1) was independently associated with incident ASCVD events (HR: 3.33; p=0.001), with event rates increasing significantly with higher CAC scores.

Conclusions:

  • Coronary artery calcium (CAC) is an independent predictor of ASCVD events in familial hypercholesterolemia (FH) patients on lipid-lowering therapy.
  • CAC scoring can enhance risk stratification for FH patients, identifying those who may benefit from intensified treatment.
  • This study supports the use of CAC to refine risk assessment in primary prevention for FH individuals.
Abstract

Related Concept Videos

Family Therapy01:30

Family Therapy

Family therapy conceptualizes psychological challenges as arising from dysfunctional interactions within the family unit, rather than as isolated issues within individuals. This approach seeks to address and transform the patterns of communication, roles, and relationships within families to promote healthier dynamics and emotional well-being for all members.
Strategic Family Therapy
Strategic family therapy emphasizes resolving communication barriers and improving problem-solving abilities...
598
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.9K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.4K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
16.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
451